03/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

03/2024

Mar 10, 2024, 15:30 | Blog
Lola Fashoyin-Aje: An amazing first week at the FDA Center for Biologics Evaluation and Research
Lola Fashoyin-Aje, Director, Office of Clinical Evaluation (Cell and Gene Therapies) at FDA, shared a post on…
Mar 10, 2024, 15:26 | Blog
Alamin Hossain: 9 AI websites that can create presentations in just 60 seconds!
Alamin Hossain, Founder of 8020AI, shared a post on LinkedIn: "RIP Powerpoint? No more wasted time…
Mar 10, 2024, 15:22 | Blog
Alique Topalian: Biomarker testing is the future of cancer care and helped in the fight to save my life
Alique Topalian, Research Scientist- Survivorship and Supportive Services at University of Cincinnati Cancer Center, shared a…
Mar 10, 2024, 15:19 | Blog
Erika Bergeron: My first ever publication highlights the importance of Community Health Navigators adults who use American Sign Language
Erika Bergeron, Associate Clinical Research Coordinator at Center for Deaf Health Equity, shared a post on…
Mar 10, 2024, 12:31 | Drugs
Fadi Haddad: P1/2 study of pivekimab
Fadi Haddad, Assistant Professor, Leukemia Department MD Anderson Cancer Center, Houston, shared a post on X/Twitter:…
Mar 10, 2024, 12:27 | Blog
Sanam Loghavi: Our book is here
Sanam Loghavi shared a post on X/Twitter: “Today is the day….Our book is here. It’s…
Mar 10, 2024, 12:24 | Blog
Vivek Subbiah: Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer
Vivek Subbiah shared a post on X/Twitter: “Hot off the press presenting to the Nature…
Mar 10, 2024, 12:17 | Blog
Amy Ware: I've been particularly impressed by people I've met and partnered with since joining HCA Healthcare | TriStar Division and Sarah Cannon Cancer Institute
Amy Ware, Associate Regional Vice President of Oncology at HCA Healthcare, shared on LinkedIn: “I've…
Mar 10, 2024, 12:13 | Blog
Ignacio Gil-Bazo: A mechanism of action through which anti-TIGIT inhibitors can modify immunosuppressive tumor microenvironments
Ignacio Gil-Bazo, Scientific Director and Head of Department of Oncology at Valenciano Institute of Oncology,…
Mar 10, 2024, 12:11 | Blog
The Local Evidence Campaign of CANCaRe Africa is starting NOW - CANCaRe Africa
Quoting CANCaRe Africa on X/Twitter: “The Local Evidence Campaign of CANCaRe Africa is starting NOW!…
All: 860 Posts: 611 - 620
Special Coverage